エプスタイン－バーウイルスを標的とするＴＣＲ－Ｔ細胞療法 - Guandon TC R Cure By Offerma Technology Company Limited

Title:

エプスタイン－バーウイルスを標的とするＴＣＲ－Ｔ細胞療法

Document Type and Number:

Japanese Patent JP2023528630

Kind Code:

A

Abstract:

エプスタイン-バーウイルス（EBV）抗原を認識するかまたはそれに結合するT細胞受容体、遺伝子操作された細胞、および細胞ベースの治療法を提供する。TIFF2023528630000008.tif15170

More Like This:

JP2021520798	Mammalian MHC peptide display as an epitope selection tool for vaccine design
JP2021518161	Gene Regulatory Compositions and Methods for Improving Immunotherapy
WO/2001/038385	A NEW POLYPEPTIDE-HUMAN PHOSPHATASE 79 AND THE POLYNUCLEOTIDE ENCODING IT

Inventors:

Wu Haiyan
Zhou Jie
Den Dachuan
Rishi
Zao Licia
Chan Luu
Chen Louis
Bryson Paul
Mudgar Poorva Prakash

Application Number:

JP2022574384A

Publication Date:

July 05, 2023

Filing Date:

June 04, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Guandon TC R Cure By Offerma Technology Company Limited
TC R Cure By Offerma Corporation

International Classes:

C12N15/12; A61K35/17; A61K35/76; A61K39/395; A61K45/00; A61K48/00; A61P31/22; A61P35/00; A61P43/00; C07K14/725; C12N1/15; C12N1/19; C12N1/21; C12N5/0783; C12N5/10; C12N15/63; C12N15/86; C12N15/867

Attorney, Agent or Firm:

Hatsushi Shimizu
Masao Haruna
Hirotaka Yamaguchi
Shun Jinbe
Ryuichi Inoue
Toshimitsu Sato
Kousuke Umemura
Koichi Niimi
Tomohiko Kobayashi
Hideki Kodera
Masato Ozeki
Maki Shioda
Kazuya Kawamoto

Previous Patent: Tocopherol-based nonionic and anionic surfactants

Next Patent: Power tool device and method